Lutz Heinemann

Lutz Heinemann (born 1954) is a German biologist whose research is focused on insulin pharmacology and diabetes technology.

He graduated with a degree in process engineering from the University of Applied Sciences, Düsseldorf, Germany, in 1976, and qualified as a biologist at the Heinrich Heine University Düsseldorf in 1982. He worked as a faculty member at the Heinrich Heine University Düsseldorf.

He has been Managing Editor of the ''Journal of Diabetes Science and Technology'' since 2011.

He received an award for Leadership in Diabetes Technology from the Diabetes Technology Society in 2007, and was awarded the Artificial Pancreas Research Award from the Diabetes Technology Society in 2012. He has an h-index of 81 according to Google Scholar. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Lutz Heinemann', query time: 0.04s Refine Results
  1. 1
    Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice

    Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice by Lutz Heinemann, Christopher G. Parkin

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Diabetes management intervention studies: lessons learned from two studies

    Diabetes management intervention studies: lessons learned from two studies by Bettina Petersen, Iris Vesper, Bernhild Pachwald, Nicole Dagenbach, Sina Buck, Delia Waldenmaier, Lutz Heinemann

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study

    Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic an... by Norbert Hermanns, Stefan Pleus, Cornelia Haug, Guido Freckmann, Lutz Heinemann, Delia Waldenmaier, Dominic Ehrmann

    Published 2021-03-01
    Get full text
    Article
  4. 4
    „Auf die Digitalisierung muss jeder eine eigene Antwort finden“

    „Auf die Digitalisierung muss jeder eine eigene Antwort finden“ by Michael Bollessen, Prof. Dr. Dipl. Psych. Bernhard Kulzer, Prof. Dr. rer. nat. Lutz Heinemann, Dr. Anja Selig, Peter Stegmaier

    Published 2021-06-01
    Get full text
    Article
  5. 5
    The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

    The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). by Hubert Kolb, Kathrin Lückemeyer, Tim Heise, Christian Herder, Nanette C Schloot, Wolfgang Koenig, Lutz Heinemann, Stephan Martin, DIATOR Study Group

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).

    Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). by Alexander Strom, Hubert Kolb, Stephan Martin, Christian Herder, Marie-Christine Simon, Wolfgang Koenig, Tim Heise, Lutz Heinemann, Michael Roden, Nanette C Schloot, DIATOR Study Group

    Published 2012-01-01
    Get full text
    Article
  7. 7
    Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions

    Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions by Malte Jacobsen, Till A. Dembek, Athanasios-Panagiotis Ziakos, Rahil Gholamipoor, Guido Kobbe, Markus Kollmann, Christopher Blum, Dirk Müller-Wieland, Andreas Napp, Lutz Heinemann, Nikolas Deubner, Nikolaus Marx, Stefan Isenmann, Melchior Seyfarth

    Published 2020-09-01
    Get full text
    Article
  8. 8
    Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies

    Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies by Malte Jacobsen, Rahil Gholamipoor, Till A. Dembek, Pauline Rottmann, Marlo Verket, Julia Brandts, Paul Jäger, Ben-Niklas Baermann, Mustafa Kondakci, Lutz Heinemann, Anna L. Gerke, Nikolaus Marx, Dirk Müller-Wieland, Kathrin Möllenhoff, Melchior Seyfarth, Markus Kollmann, Guido Kobbe

    Published 2023-06-01
    Get full text
    Article

Search Tools: